Plunkett Research Online: Aikido Pharma Inc

AIKIDO PHARMA INC (AIKI:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Aikido Pharma, Inc. is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The firm’s platform consists of patented technology from leading universities and researchers and it is currently in the process of developing an innovativ.....



Aikido Pharma Inc
Ticker: AIKI
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 703-992-9325
Fax:
Address: One Rockefeller Plaza
11th Floor
New York, NY 10020 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Biotechnology Research & Development
Biotechnology
Anticancer Therapeutics
Antiviral Therapeutics
Contacts Description

Anthony Hayes CEO/CFO/Chief Accounting Officer/Director
Robert Vander Zanden Chairman of the Board/Director
See More
Aikido Pharma, Inc. is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The firm’s platform consists of patented technology from leading universities and researchers and it is currently in the process of developing an innovativ.....See More See More

Auditor: Marcum LLP
Legal Advisor: Sichenzia Ross Friedman Ference LLP
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016 2015
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Hoth Therapies
DatChat Inc
CBM BioPharma Inc
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: